We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

27 hedge funds and large institutions have $6.67M invested in Dare Bioscience in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

600% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 1

200% more capital invested

Capital invested by funds: $2.22M → $6.67M (+$4.45M)

29% more funds holding

Funds holding: 21 → 27 (+6)

0.42% more ownership

Funds ownership: 0.59% → 1.01% (+0.42%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
27
Holders Change
+6
Holders Change %
+28.57%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
8
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.52M
2
GCP
GSA Capital Partners
United Kingdom
+$169K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$143K
4
Goldman Sachs
Goldman Sachs
New York
+$135K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$135K

Top Sellers

Rank Fund Capital Flow
1
RJA
Raymond James & Associates
Florida
-$17K
2
TRCT
Tower Research Capital (TRC)
New York
-$8.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.01M +$2.52M +179,700 +258%
Renaissance Technologies
2
Renaissance Technologies
New York
$948K +$4.79K +342 +0.6%
PVMCV
3
Polaris Venture Management Co V
Massachusetts
$437K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$282K +$143K +10,235 +139%
GCP
5
GSA Capital Partners
United Kingdom
$193K +$169K +12,027 New
Two Sigma Advisers
6
Two Sigma Advisers
New York
$155K +$135K +9,633 New
Goldman Sachs
7
Goldman Sachs
New York
$155K +$135K +9,664 New
Citadel Advisors
8
Citadel Advisors
Florida
$87K +$75.4K +5,381 New
Northern Trust
9
Northern Trust
Illinois
$83K +$2.51K +179 +4%
FFS
10
Founders Financial Securities
Maryland
$67K – – –
IVM
11
InterWest Venture Management
California
$67K – – –
HighTower Advisors
12
HighTower Advisors
Illinois
$42K +$9.35K +667 +33%
Two Sigma Investments
13
Two Sigma Investments
New York
$39K +$34.1K +2,433 New
VF
14
Virtu Financial
New York
$31K +$4.39K +313 +19%
PTP
15
Platform Technology Partners
New York
$20K +$17.5K +1,250 New
UCFA
16
United Capital Financial Advisors
Texas
$18K +$1.05K +75 +7%
RFA
17
Reilly Financial Advisors
California
$9K – – –
FDCDDQ
18
Federation des caisses Desjardins du Quebec
Quebec, Canada
$8.71K – – –
Osaic Holdings
19
Osaic Holdings
Arizona
$8K – – –
TRCT
20
Tower Research Capital (TRC)
New York
$6K -$8.7K -621 -61%
EWM
21
Edge Wealth Management
New York
$4K – – –
AWA
22
Artemis Wealth Advisors
New York
$1.18K – – –
BlackRock
23
BlackRock
New York
$1K – – –
UBS Group
24
UBS Group
Switzerland
$1K – – –
IA
25
Inspire Advisors
Idaho
$1K +$546 +39 New
1
2

DARE Hedge Fund Activity: Q4 2020 in Review

27 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2020, worth a combined $6.67M — up 200% from $2.22M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new DARE positions and 1 closed out — a net gain of 6 holders — while 8 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.52M. The largest seller was Raymond James & Associates, exiting entirely with an estimated $17K sold.

  • 27 institutional investors held Dare Bioscience (DARE) as of Q4 2020, up from 21 in Q3 2020.
  • Funds reported $6.67M of Dare Bioscience stock for Q4 2020, up 200% quarter-over-quarter.
  • 7 funds opened new Dare Bioscience positions in Q4 2020 and 1 closed out, a net change of +6 holders.
  • The largest Dare Bioscience buyer in Q4 2020 was Vanguard Group, an estimated $2.52M added.
  • The largest Dare Bioscience seller in Q4 2020 was Raymond James & Associates, an estimated $17K sold.

Based on aggregated 13F filings for Q4 2020.